|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the ELN 6-K filed Mar 31, 2006. Investment Gains
Investment gains amounted to $17.9 million for 2005,
compared to $163.9 million for 2004. The gains on
investments in 2005 primarily relate to gains on the disposal of
investments in Allergy Therapeutics, plc. of $10.0 million,
Iomai Corporation (Iomai) of $3.2 million, and Emisphere
Technologies, Inc. (Emisphere) of $1.7 million. In 2004,
the gains on investments included gains on the disposal of
investments in DOV Pharmaceuticals, Inc. of $49.1 million,
Warner Chilcott, plc of $43.6 million, and Atrix
Laboratories of $27.7 million.
|
| |||||||
